Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
May 29  •  04:00PM ET
62.34
Dollar change
-0.52
Percentage change
-0.83
%
Index
NDX, S&P 500
P/E
14.92
EPS (ttm)
4.18
Insider Own
0.29%
Shs Outstand
454.89M
Perf Week
-3.09%
Market Cap
28.36B
Forward P/E
11.53
EPS next Y
5.41
Insider Trans
8.53%
Shs Float
453.55M
Perf Month
4.80%
Enterprise Value
36.88B
PEG
1.22
EPS next Q
1.03
Inst Own
88.09%
Perf Quarter
-26.02%
Income
1.91B
P/S
1.35
EPS this Y
6.27%
Inst Trans
-1.98%
Perf Half Y
-22.04%
Sales
20.98B
P/B
2.66
EPS next Y
10.86%
ROA
5.40%
Perf YTD
-23.99%
Book/sh
23.45
P/C
12.41
EPS next 5Y
9.45%
ROE
19.24%
52W High
89.77 -30.56%
Perf Year
-12.85%
Cash/sh
5.02
P/FCF
18.67
EPS past 3/5Y
2.53% 0.61%
ROIC
9.05%
52W Low
58.75 6.11%
Perf 3Y
-20.52%
EV/EBITDA
10.84
Sales past 3/5Y
3.99% 3.74%
Gross Margin
38.84%
Volatility
2.30% 2.72%
Perf 5Y
-
EV/Sales
1.76
EPS Y/Y TTM
-12.36%
Oper. Margin
13.38%
ATR (14)
1.91
Perf 10Y
-
Quick Ratio
0.89
Sales Y/Y TTM
5.97%
Profit Margin
9.10%
RSI (14)
41.26
Current Ratio
1.17
EPS Q/Q
-30.73%
SMA20
-0.10%
Beta
0.87
Debt/Eq
0.99
Sales Q/Q
7.41%
SMA50
-7.55%
Rel Volume
1.20
Prev Close
62.86
Employees
54000
LT Debt/Eq
0.98
SMA200
-17.28%
Avg Volume
4.66M
Price
62.34
IPO
Dec 15, 2022
Option/Short
Yes / Yes
Trades
Volume
5,609,952
Change
-0.83%
Date Action Analyst Rating Change Price Target Change
May-21-26Upgrade UBS Sell → Neutral $69
Apr-30-26Downgrade Goldman Buy → Neutral $65
Jan-15-26Downgrade UBS Neutral → Sell $77
Oct-13-25Initiated Barclays Equal Weight $86
Oct-07-25Downgrade Citigroup Buy → Neutral $83
May-05-25Upgrade UBS Sell → Neutral $73
Mar-11-25Upgrade Goldman Neutral → Buy $85 → $100
Jan-08-25Upgrade Jefferies Hold → Buy $95 → $103
Sep-26-24Downgrade UBS Neutral → Sell $84 → $74
Sep-18-24Upgrade BTIG Research Neutral → Buy $100
May-21-26 09:40AM
May-19-26 08:55AM
May-14-26 07:21AM
May-12-26 09:00AM
May-11-26 09:00AM
12:28PM Loading…
Apr-30-26 12:28PM
09:36AM
Apr-29-26 12:55PM
10:55AM
08:56AM
08:23AM
07:51AM
07:00AM
06:59AM
06:27AM
06:20AM Loading…
06:20AM
06:20AM
Apr-27-26 07:00AM
Apr-23-26 07:29AM
Apr-17-26 11:28AM
07:15AM
Apr-16-26 04:05PM
Apr-06-26 07:00AM
Mar-31-26 04:10PM
Mar-27-26 09:30AM
Mar-26-26 08:30AM
Mar-25-26 09:00AM
Mar-24-26 07:51AM
06:00AM
Mar-23-26 09:59AM
04:00PM Loading…
Mar-18-26 04:00PM
Mar-17-26 09:00AM
Mar-12-26 04:51PM
Mar-11-26 05:45AM
05:26AM
Mar-10-26 01:39PM
01:11PM
Mar-09-26 09:00AM
Mar-05-26 09:33AM
09:00AM
Mar-04-26 12:30PM
10:50AM
12:38AM
Mar-03-26 12:19PM
10:15AM
09:50AM
Mar-02-26 08:31AM
Feb-28-26 11:57AM
Feb-27-26 11:07PM
12:45PM
12:37PM
11:40AM
Feb-26-26 11:46AM
11:14AM
Feb-25-26 12:51PM
12:49PM
11:57AM
09:40AM
Feb-24-26 12:15PM
09:40AM
Feb-23-26 11:44PM
03:43PM
07:21AM
Feb-20-26 04:58PM
01:02PM
12:22PM
11:44AM
09:04AM
07:29AM
Feb-19-26 09:00AM
08:04AM
07:56AM
Feb-18-26 01:09PM
10:53AM
09:51AM
09:48AM
02:32AM
Feb-17-26 03:32PM
11:20AM
11:12AM
09:00AM
Feb-16-26 11:32AM
10:52AM
09:42AM
Feb-15-26 06:53AM
Feb-12-26 06:11PM
12:57PM
11:03AM
07:30AM
Feb-11-26 11:40AM
12:36AM
Feb-10-26 12:20PM
Feb-09-26 12:06PM
10:40AM
08:00AM
Feb-06-26 08:53AM
07:05AM
Feb-05-26 12:44PM
09:00AM
12:35AM
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment provides scanning devices, clinical applications, service capabilities, and digital solutions. The AVS segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The PCS segment specializes in providing medical devices, consumables, services, and digital solutions. The PDx segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company was founded in 1892. It was incorporated on May 16, 2022 and is headquartered in Chicago, IL.
PresidentMr. Peter J. Arduini
VP & CFOMr. James K. Saccaro
M.S.Dr. Taha Kass-Hout M.D.
General Counsel & Corporate SecretaryMr. Frank R. Jimenez Esq.
President & CEO of Patient Care SolutionsMs. Jeannette Bankes
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lobo KevinDirectorMay 22 '26Buy64.1810,000641,80014,363May 26 06:44 PM
Hochman Rodney FDirectorMay 12 '26Buy62.031,618100,3651,618May 13 04:19 PM
Yang Watkin Phoebe L.DirectorMay 08 '26Buy63.011,00063,00613,702May 11 08:16 PM
CULP H LAWRENCE JRDirectorMay 06 '26Buy61.8880,8055,000,076151,207May 07 04:14 PM
Stromberg William JDirectorMay 06 '26Buy61.691,00061,68915,330May 07 04:09 PM
SACCARO JAMESChief Financial OfficerMay 01 '26Buy60.603,310200,58587,471May 01 11:38 AM
Jimenez Frank RGC & Corporate SecretaryApr 30 '26Buy60.451,750105,78893,932Apr 30 04:21 PM
Arduini Peter JPresident and CEOApr 30 '26Buy59.924,169249,827259,424Apr 30 04:20 PM
Kenneth StacherskiFormer OfficerNov 24 '25Proposed Sale77.004,585353,045Nov 24 04:24 PM
Kenneth StacherskiFormer OfficerOct 27 '25Proposed Sale78.954,585361,993Oct 27 04:26 PM
Kenneth StacherskiFormer OfficerSep 22 '25Proposed Sale74.4619,5241,453,773Sep 22 04:44 PM
Kenneth StacherskiFormer OfficerSep 12 '25Proposed Sale77.0311,757905,590Sep 12 04:47 PM
Rott RolandCEO, ImagingSep 11 '25Option Exercise55.915,341298,59232,128Sep 12 04:05 PM
Last Close
May 29  •  04:00PM ET
305.09
Dollar change
-2.54
Percentage change
-0.83
%
SYK Stryker Corp daily Stock Chart
Index
S&P 500
P/E
35.34
EPS (ttm)
8.63
Insider Own
6.07%
Shs Outstand
383.40M
Perf Week
-2.68%
Market Cap
116.96B
Forward P/E
18.22
EPS next Y
16.74
Insider Trans
-3.42%
Shs Float
360.08M
Perf Month
-3.19%
Enterprise Value
129.23B
PEG
1.65
EPS next Q
3.49
Inst Own
80.17%
Perf Quarter
-21.26%
Income
3.34B
P/S
4.63
EPS this Y
9.90%
Inst Trans
-0.78%
Perf Half Y
-18.66%
Sales
25.27B
P/B
5.09
EPS next Y
11.77%
ROA
7.23%
Perf YTD
-13.20%
Book/sh
59.93
P/C
39.45
EPS next 5Y
11.06%
ROE
15.20%
52W High
404.87 -24.64%
Perf Year
-20.21%
Cash/sh
7.73
P/FCF
25.59
EPS past 3/5Y
10.83% 14.84%
ROIC
8.89%
52W Low
281.00 8.57%
Perf 3Y
11.93%
EV/EBITDA
18.36
Sales past 3/5Y
10.83% 11.84%
Gross Margin
61.97%
Volatility
2.61% 2.90%
Perf 5Y
19.52%
EV/Sales
5.11
EPS Y/Y TTM
16.34%
Oper. Margin
23.02%
ATR (14)
8.69
Perf 10Y
172.96%
Quick Ratio
1.25
Sales Y/Y TTM
8.84%
Profit Margin
13.21%
RSI (14)
44.02
Current Ratio
2.11
EPS Q/Q
13.88%
SMA20
0.72%
Beta
0.79
Debt/Eq
0.66
Sales Q/Q
2.63%
SMA50
-4.84%
Rel Volume
2.45
Prev Close
307.63
Employees
56000
LT Debt/Eq
0.63
SMA200
-14.42%
Avg Volume
2.40M
Price
305.09
IPO
Mar 17, 1980
Option/Short
Yes / Yes
Trades
Volume
5,895,274
Change
-0.83%
Date Action Analyst Rating Change Price Target Change
Apr-13-26Initiated Leerink Partners Outperform $410
Feb-20-26Initiated William Blair Outperform
Jan-27-26Resumed TD Cowen Hold $387
Jan-06-26Upgrade Raymond James Mkt Perform → Outperform $418
Dec-19-25Upgrade Citizens JMP Mkt Perform → Mkt Outperform $440
Sep-18-25Initiated Rothschild & Co Redburn Neutral $420
Feb-26-25Resumed Citigroup Buy $450
Dec-02-24Upgrade Morgan Stanley Equal-Weight → Overweight $370 → $445
Sep-10-24Initiated Wolfe Research Outperform $405
May-30-24Initiated Goldman Neutral $372
May-26-26 02:10AM
May-21-26 07:06AM
06:42AM
May-19-26 05:30AM
May-14-26 05:18PM
07:08AM Loading…
May-13-26 07:08AM
05:07AM
May-12-26 06:56AM
May-08-26 06:57AM
May-07-26 04:05PM
08:00AM
May-01-26 11:17AM
08:00AM
03:19AM
Apr-30-26 05:41PM
04:14PM Loading…
04:14PM
04:05PM
Apr-20-26 11:18AM
Apr-14-26 11:44PM
Apr-13-26 11:51AM
09:58AM
08:00AM
07:15AM
Apr-10-26 07:58AM
06:54AM
Apr-01-26 08:00AM
Mar-31-26 08:00AM
Mar-27-26 07:02AM
Mar-26-26 12:54PM
Mar-25-26 08:31AM
03:00PM Loading…
Mar-23-26 03:00PM
06:43AM
Mar-19-26 03:51PM
Mar-18-26 01:39PM
11:57AM
Mar-17-26 11:01AM
09:00AM
Mar-16-26 03:40AM
Mar-13-26 02:38PM
10:49AM
08:43AM
07:59AM
Mar-12-26 06:03PM
02:05PM
06:46AM
Mar-11-26 09:09PM
03:20PM
02:25PM
02:20PM
11:48AM
05:20AM
Mar-10-26 01:39PM
01:14PM
Mar-09-26 09:07AM
Mar-04-26 10:50AM
05:28AM
Mar-03-26 08:00AM
Feb-28-26 09:11PM
Feb-27-26 11:40AM
Feb-26-26 11:21AM
11:06AM
Feb-25-26 11:57AM
06:07AM
Feb-24-26 06:01PM
08:41AM
Feb-23-26 03:38PM
Feb-20-26 09:39AM
09:04AM
Feb-16-26 09:55AM
Feb-13-26 07:57AM
Feb-12-26 12:57PM
08:27AM
Feb-11-26 11:40AM
11:14AM
09:03AM
Feb-10-26 05:00AM
Feb-09-26 10:29AM
Feb-05-26 10:42AM
Feb-04-26 08:00AM
Feb-03-26 08:08PM
Jan-30-26 02:31PM
12:28PM
10:25AM
07:56AM
02:08AM
12:04AM
Jan-29-26 10:55PM
06:00PM
05:25PM
05:01PM
04:56PM
04:29PM
04:05PM
Jan-28-26 08:24AM
Jan-27-26 10:13PM
09:37AM
Jan-26-26 10:20AM
09:50AM
09:50AM
09:15AM
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.
Chairman & CEOMr. Kevin A. Lobo
President & COOMr. Spencer S. Stiles
VP & CFOMr. Preston W. Wells
Group President of Global Quality & OperationsMr. Viju S. Menon
Group President of MedSurg & NeurotechnologyMr. J. Andrew Pierce
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fletcher Robert SVP, Chief Legal OfficerMay 28 '26Sale306.874,5441,394,40910,582May 29 04:59 PM
STRYKER RONDA EDirectorMay 26 '26Sale312.23310,00096,792,6691,924,880May 28 05:22 PM
Fletcher Robert SOfficerMay 28 '26Proposed Sale305.594,5441,388,601May 28 04:48 PM
STRYKER RONDA EDirectorMay 26 '26Proposed Sale313.00310,00097,030,000May 27 08:49 AM
Fink M KathrynVP, Chief HR OfficerMay 08 '26Option Exercise167.9821,5823,625,38834,719May 12 04:37 PM
Fink M KathrynVP, Chief HR OfficerMay 11 '26Sale283.855,2201,481,67113,137May 12 04:37 PM
Fink M KathrynVP, Chief HR OfficerMay 11 '26Sale283.453,500992,085177May 12 04:37 PM
Mary FinkOfficerMay 11 '26Proposed Sale283.845,2201,481,665May 11 03:27 PM
2023 Mary Fink Living TrustOfficerMay 11 '26Proposed Sale283.403,500991,884May 11 03:11 PM
Stiles Spencer SPresident and COOMar 21 '26Option Exercise0.00430084,324Mar 24 05:17 PM
Pierce James AndrewGroup PresidentMar 21 '26Option Exercise0.00430088,676Mar 24 05:14 PM
Menon VijuGroup PresidentMar 21 '26Option Exercise0.00269022,100Mar 24 05:11 PM
Lobo KevinChair and CEOMar 21 '26Option Exercise0.001,4520248,723Mar 24 05:07 PM
Fletcher Robert SVP, Chief Legal OfficerMar 21 '26Option Exercise0.00225018,510Mar 24 05:04 PM
Fink M KathrynVP, Chief HR OfficerMar 21 '26Option Exercise0.00150018,701Mar 24 04:59 PM
STRYKER RONDA EDirectorFeb 05 '26Sale363.95250,00090,988,5282,207,331Feb 06 06:21 PM
STRYKER RONDA EDirectorFeb 04 '26Sale362.92250,00090,730,7412,457,331Feb 06 06:21 PM
Lobo KevinChair and CEOFeb 06 '26Option Exercise96.64206,95520,000,131329,350Feb 06 04:18 PM
Stiles Spencer SPresident and COOFeb 03 '26Option Exercise96.6413,8401,337,49876,674Feb 04 05:00 PM
Pierce James AndrewGroup PresidentFeb 02 '26Option Exercise96.6413,8401,337,49879,470Feb 03 04:09 PM
Pierce James AndrewGroup PresidentFeb 02 '26Sale368.87475175,21570,563Feb 03 04:09 PM
James Andrew PierceOfficerFeb 02 '26Proposed Sale368.87475175,214Feb 02 03:09 PM
Silvernail Andrew KDirectorJan 15 '26Option Exercise96.644,570441,64518,932Jan 16 04:42 PM
STRYKER RONDA EDirectorJan 14 '26Option Exercise96.644,570441,6455,783Jan 14 05:35 PM
Wells Preston WendellVP, Chief Financial OfficerNov 20 '25Sale365.8816560,3706,694Nov 20 04:22 PM
Preston WellsOfficerNov 20 '25Proposed Sale365.8816560,370Nov 20 12:03 PM
Berry William E JrVP, Chief Accounting OfficerNov 14 '25Option Exercise154.144,925759,1397,758Nov 17 04:21 PM
Berry William E JrVP, Chief Accounting OfficerNov 14 '25Sale365.491,953713,8022,833Nov 17 04:21 PM
William Berry JrOfficerNov 14 '25Proposed Sale365.492,026740,482Nov 14 04:27 PM
STRYKER RONDA EDirectorNov 06 '25Sale353.28276,17397,565,6942,702,108Nov 07 04:22 PM
STRYKER RONDA EDirectorNov 05 '25Sale356.98243,82787,040,4472,978,281Nov 07 04:22 PM
STRYKER RONDA EDirectorNov 05 '25Proposed Sale355.00520,000184,600,000Nov 05 03:40 PM
Menon VijuGroup PresidentAug 25 '25Sale390.61500195,30512,511Aug 27 04:32 PM
Viju MenonOfficerAug 25 '25Proposed Sale390.61500195,305Aug 25 12:17 PM
Fletcher Robert SVP, Chief Legal OfficerAug 20 '25Sale393.071,785701,63010,457Aug 21 04:06 PM
Robert FletcherOfficerAug 20 '25Proposed Sale393.061,785701,620Aug 20 04:05 PM
STRYKER RONDA EDirectorAug 06 '25Sale376.45200,00075,289,6553,222,108Aug 07 04:36 PM